Over 140,000 bottles of cholesterol-lowering drug recalled: Safety concerns with Atorvastatin calcium tablets

Federal health officials have announced a major recall affecting more than 140,000 bottles of a widely used cholesterol-lowering drug. The medication, a generic form of Lipitor, failed key laboratory standards, prompting concerns about its effectiveness in managing cholesterol levels and preventing heart-related conditions.

ALSO READ: 3I/ATLAS: Harvard professor reveals new details - here are the comet's features

What led to the recall?

According to the U.S. Food and Drug Administration (FDA), several bottle sizes of Atorvastatin Calcium Tablets, 10 mg (Prescription Only), are being recalled due to “failed dissolution specifications.” This means the tablets did not dissolve as expected during testing, which could make them less effective in controlling cholesterol levels, as per a report by Fox Business.


ALSO READ: Egg recall hits FDA’s highest alert — 6 million items must be thrown out immediately

Atorvastatin Calcium Tablets are the generic form of Lipitor and belong to a group of medicines known as statins. These drugs work by blocking an enzyme in the liver that helps the body produce cholesterol, lowering the risk of heart disease, strokes, and heart attacks, as per a report by Fox Business.

How serious is the recall?

The FDA classified the recall as Class II, which applies when using or being exposed to the product “may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”

ALSO READ: This iPhone 17 problem is driving users crazy — Apple needs to fix it fast

Eight lot numbers are affected, with expiration dates ranging from July 2026 to February 2027. The impacted bottle sizes include 90 tablets, 500 tablets, and 1,000 tablets, as per a report by Fox Business.

Which batches are affected?

The recalled batches were manufactured by Alkem Laboratories and distributed by Ascend Laboratories LLC. The total number of bottles affected exceeds 140,000, according to the FDA’s enforcement report. Consumers using this medication are advised to consult their healthcare provider if they have any concerns about thei, as per a report by Fox Business. prescriptions.

ALSO READ:Meta layoffs: After offering billion dollar pay packages, Mark Zuckerberg-led firm to cut 600 AI jobs

FAQs

Why are Atorvastatin Calcium Tablets being recalled?
They failed to meet dissolution standards, meaning the tablets may not dissolve properly, affecting how they work in the body.

Who manufactured and distributed the recalled drug?
The medication was manufactured by Alkem Laboratories and distributed by Ascend Laboratories LLC.